Log in | Register

Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 11, Issue 5

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Drug Safety, Volume 11, Issue 5 (2012)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Safety, Volume 11, Issue 5 (2012)

See all volumes and issues

Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Volume 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Research Article

Article

Related articles

Page: 1

Published online: 23 Aug 2012

41 Views
0 CrossRef citations
0Altmetric

Editorial

Two anti-obesity hopefuls and their safety

Nicholas T Bello PhD & Sara C Campbell PhD

Pages: 681-683

Published online: 13 Jul 2012

First Page PreviewforTwo anti-obesity hopefuls and their safety | Full Text | References | PDF (164.6 KB)

980 Views
1 CrossRef citations
0Altmetric

Free Access

Editorial

Antidepressant up-titration: pharmacological and psychological considerations

Riccardo GV Torta

Pages: 685-688

Published online: 06 Aug 2012

AbstractforAntidepressant up-titration: pharmacological and psychological considerations | Full Text | References | PDF (160.2 KB)

15274 Views
3 CrossRef citations
0Altmetric

Free Access

Original Research

Article

Safety evaluation of cephalosporins based on utilization and adverse drug events: analysis of two databases in China

Xiuhua Ren, Dong Liu, Nan Ding, Kun Huang, Yongshan Xiong, Guang Du & Fandian Zeng

Pages: 689-697

Published online: 19 Jun 2012

AbstractforSafety evaluation of cephalosporins based on utilization and adverse drug events: analysis of two databases in China | Full Text | References | PDF (258.4 KB)

375 Views
8 CrossRef citations
0Altmetric

Article

Tolerability aspects in duloxetine-treated patients with depression: should one use a lower starting dose in clinical practice?

Stefan Wilhelm MD, Frank G Boess PhD, Ulrich Hegerl MD, Roland Mergl PhD, Michael Linden MD, Alexander Schacht PhD & Edith Schneider MD

Pages: 699-711

Published online: 20 Jun 2012

AbstractforTolerability aspects in duloxetine-treated patients with depression: should one use a lower starting dose in clinical practice? | Full Text | References | PDF (293.7 KB)

216 Views
2 CrossRef citations
0Altmetric

Article

Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis

Hoda Moteshafi & Emmanuel Stip MD MSc FRCP DPAPA

Pages: 713-732

Published online: 23 Aug 2012

AbstractforComparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis | Full Text | References | PDF (473.3 KB)

749 Views
13 CrossRef citations
0Altmetric

Article

Statin use and the risk of bladder cancer: a population-based case–control study

Chien-Chun Kuo MD, Hui-Fen Chiu PhD, I-Ming Lee MD MS, Hsin-Wei Kuo MD PhD, Chien-Te Lee MD & Chun-Yuh Yang PhD MPH

Pages: 733-738

Published online: 31 Jul 2012

AbstractforStatin use and the risk of bladder cancer: a population-based case–control study | Full Text | References | PDF (183.5 KB)

242 Views
6 CrossRef citations
0Altmetric

Reviews

Review Article

Antineoplastic drug-induced bradyarrhythmias

Carla Minoia MD, Margherita Giannoccaro MD, Angela Iacobazzi MD, Daniele Santini MD, Nicola Silvestris MD, Agnese Fioretti MD, Stefano Oliva MD & Attilio Guarini MD

Pages: 739-751

Published online: 13 Jul 2012

AbstractforAntineoplastic drug-induced bradyarrhythmias | Full Text | References | PDF (240.1 KB)

335 Views
10 CrossRef citations
0Altmetric

Review Article

Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects

Arrigo FG Cicero MD PhD, Alienor Ferroni MD & Sibel Ertek MD PhD

Pages: 753-766

Published online: 13 Jul 2012

AbstractforTolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects | Full Text | References | PDF (240.2 KB)

614 Views
52 CrossRef citations
0Altmetric

Review Article

Anticonvulsant hypersensitivity syndrome: an update

Sandra R Knowles BScPhm, Norman Dewhurst PharmD & Neil H Shear MD

Pages: 767-778

Published online: 14 Jul 2012

AbstractforAnticonvulsant hypersensitivity syndrome: an update | Full Text | References | PDF (231 KB)

1611 Views
32 CrossRef citations
0Altmetric

Review Article

Drug-induced gynecomastia: an evidence-based review

Fnu Deepinder MD & Glenn D Braunstein MD

Pages: 779-795

Published online: 06 Aug 2012

AbstractforDrug-induced gynecomastia: an evidence-based review | Full Text | References | PDF (291.9 KB)

3131 Views
82 CrossRef citations
0Altmetric

Review Article

Thirty years of preclinical safety evaluation of biopharmaceuticals: did scientific progress lead to appropriate regulatory guidance?

Marlous Kooijman, Peter J.K. van Meer, Ellen H.M. Moors & Huub Schellekens

Pages: 797-801

Published online: 06 Aug 2012

AbstractforThirty years of preclinical safety evaluation of biopharmaceuticals: did scientific progress lead to appropriate regulatory guidance? | Full Text | References | PDF (177.5 KB)

374 Views
17 CrossRef citations
0Altmetric

Review Article

Safety and interactions of new antifungals in stem cell transplant recipients

Corrado Girmenia MD & Anna Paola Iori

Pages: 803-818

Published online: 23 Aug 2012

AbstractforSafety and interactions of new antifungals in stem cell transplant recipients | Full Text | References | PDF (246.3 KB)

491 Views
12 CrossRef citations
0Altmetric

Review Article

Clinical safety of biosimilar recombinant human erythropoietins

Ivo Abraham PhD & Karen MacDonald PhD

Pages: 819-840

Published online: 13 Aug 2012

AbstractforClinical safety of biosimilar recombinant human erythropoietins | Full Text | References | PDF (276.8 KB)

884 Views
38 CrossRef citations
0Altmetric

Drug Safety Evaluations

Article

Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome

Sherman M Chamberlain MD & Satish SC Rao MD PhD

Pages: 841-850

Published online: 27 Jul 2012

AbstractforSafety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome | Full Text | References | PDF (399.4 KB)

447 Views
24 CrossRef citations
0Altmetric

Article

Safety and tolerability of pazopanib in the treatment of renal cell carcinoma

Andrea Zivi, Linda Cerbone, Federica Recine & Cora N Sternberg

Pages: 851-859

Published online: 04 Aug 2012

AbstractforSafety and tolerability of pazopanib in the treatment of renal cell carcinoma | Full Text | References | PDF (243.6 KB)

654 Views
20 CrossRef citations
0Altmetric

Article

Temsirolimus: a safety and efficacy review

Ronald M. Bukowski MD

Pages: 861-879

Published online: 06 Aug 2012

Abstractfor Temsirolimus: a safety and efficacy review | Full Text | References | PDF (476.7 KB)

607 Views
30 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Post-marketing safety concerns with abrocitinib: a real-world pharmacovigilance analysis of the FDA adverse event reporting system

Zhou Zhu et al.

Article | Published online: 17 May 2024

Hematological toxicity of cyclin-dependent kinase 4/6 inhibitors in patients with breast cancer: a network meta-analysis and pharmacovigilance study

Haiying Ding et al.

Review Article | Published online: 16 May 2024

Adverse tumor events induced by Ranitidine: an analysis based on the FAERS Database

Tian Liu et al.

Article | Published online: 16 May 2024

Differences in ocular adverse events associated with phosphodiesterase-5 inhibitors: a real-world pharmacovigilance study

Guixiang Chen et al.

Article | Published online: 16 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.11, Iss.5, 2012)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?